Trial Evaluating Efficacy and Safety of Dasiglucagon in Children With Congenital Hyperinsulinism
Clinical trial NCT04172441 · COMPLETED
Trial details
- NCT number
- NCT04172441
- Sponsor
- Zealand Pharma
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-19
- Primary completion
- 2022-02-17
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.